Sign in

PanEuCOPT Pan European Commission on Photoantimicrobial Testing

@paneucopt.bsky.social
37 followers 59 following 50 posts

PanEuCOPT, aims to bring together the leading European photobiologist with their medical and pharmaceutical colleagues as well as technical companies to generate a united force allowing the implementation of photodynamic inhibition.

PostsRepliesMedia
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 14/06/2026
The Shining Through Contest just got an extension to submit your applications! Submit your applications until July 16th! Rules are still the same! paneucopt.eu/news/shining... #ShiningThrough #PanEuCOPT #COSTActions #ScienceWithoutBorders #NetorkingWorks #HorizonEU #lightday2026
020
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 08/05/2026
✨ Shine your research ✨ PanEuCOPT’s Shining Through! The contest is open for researchers, students & innovators working with light-based science. 📅 Deadline: 16 June 2026 paneucopt.eu/news/shining... #Biophotonics #ResearchImpact #Innovation #Photomedicine #PanEuCOPT
021
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 26/04/2026
We invite you to submit your application for a Dissemination Conference Grant. This call covers conferences taking place between May 15th and September 30th and remains open throughout this period. Please remember that applications must be submitted at least 30 days before the conference.
100
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 09/04/2026
It has started!!! 🤩😍
000
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 08/04/2026
Are you ready for tomorrow's event? Nothing like last minute modifications... next to the beach! ⛱️ #aveiro #portugal #paneucopt #COSTAction #scicomm
100
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 02/04/2026
Ready to discover the latest European advancements in PDI and photoantimicrobial technologies?
110
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 31/03/2026
- @biankas.bsky.social in Punta Arenas, Chile (March 6th, 2026) 🇨🇱 - Santi Nonell in Chile (March 12th, 2026) 🇨🇱 - @mmuskovic.bsky.social promoted our action on the 2nd Junior ESP Meeting (March 27th, 2026) 🌐
100
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 31/03/2026
You can’t visit Salzburg without a little local culture! After a long day of intense scientific debate, the team celebrated with a traditional dinner and a mountain of Salzburger Nockerln. 🍮 Next stop: Aveiro! 👋 4/4 #Science #Salzburg #Research
100
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 31/03/2026
Big steps forward for #CA24127! 🔬 On February 12th 2026, we had the 1st WG3 Guidelines meeting at the University of Salzburg. Experts spent the day diving into state-of-the-art protocols to standardize how we study microorganisms across the board. 🧬🇦🇹 #COSTAction #Microbiology #ScienceThread 1/4
110
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 21/03/2026
Ready to discover the latest European advancements in PDI and photoantimicrobial technologies? The @paneucopt.bsky.social network is heading to Aveiro, and we are opening the doors of our main conference to the global scientific community!
100
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 12/03/2026
New logo! New banner! New colours!
000
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 11/02/2026
Antimicrobial resistance is a global problem, and we address it with light! 💡 Within the PanEuCOPT COST Action, the contribution of all the Women members is celebrated today at the occasion of the International Day of Women and Girls in Science!
153
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 15/01/2026
With her presentation "Porphyrin-Based Photosensitizers: Light-Activated Strategies to Control Antimicrobial Resistance" she introduced her audience, students and researchers, into the field of antimicrobial Photodynamic Therapy, highlighting the importance of our COST Action PanEuCOPT.
111
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 16/12/2025
We also heard Joanna Nakonieczna (University of Gdańsk and Medical University of Gdańsk), a MC member from our COST Action presenting "Photodynamic Inactivation as a Strategy for Biofilm Eradication"! 💡 Follow us for more updates on our Action and the scientific research of our members! 👯
010
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 01/12/2025
🔬 Don't Miss the Next Biofilm Corner Webinar! 🦠 Join the ESCMID Study Group for Biofilms (ESGB) for a fascinating webinar on "Innovative strategies for biofilm eradication and new possibilities in tackling biofilm associated infections". 📅 When? Wednesday, 10th December ⏰ Time: 14:00 - 15:00 CET
222
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 27/10/2025
Our first Newsletter is here! 🤩 Read our very first Newsletter, with a Summary of our objectives and our Kick-off meeting! drive.google.com/file/d/1Yn57...
154
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 09/10/2025
Follow us for more shining updates! Great things are coming! Special thanks to @costprogramme.bsky.social for the organisation of the event and for all our members for their active and engaging participation!
121
PanEuCOPT Pan European Commission on Photoantimicrobial Testing @paneucopt.bsky.social · 09/10/2025
Today the PanEuCOPT COST Action was officially launched! The Management Committee voted for their Working Group Leaders, and from time zero we're already working and discussing how to make our field more relevant and attractive for all our stakeholders: scientists, clinicians and patients.
121